Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
08/2005
08/11/2005WO2004083394A3 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders
08/11/2005WO2003102159A3 Novel proteins and nucleic acids encoding same
08/11/2005US20050177879 Using nuclear transplantation to generate animal which express human growth hormone in mammary glands; bioreactors
08/11/2005US20050177878 Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
08/11/2005US20050176065 Biarsenical molecules label tetracycsteine polypeptides; orthogonal labelling for observing conformational changes; solid phase synthesis; kits
08/11/2005US20050175613 Compositions and methods for treating hyperimmune response in the eye
08/10/2005EP1560839A2 Chimeric oligomeric compounds and their use in gene modulation
08/10/2005EP1560821A2 Antibacterial agents
08/10/2005EP1133559B1 Human orphan g protein-coupled receptor rup3
08/04/2005WO2005071059A2 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
08/04/2005WO2005071058A2 Methods and systems for annotating biomolecular sequences
08/04/2005WO2005054426A3 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
08/04/2005WO2005049793A3 Methods and compositions for combinatorial approaches to cancer gene therapy
08/04/2005WO2005047457A3 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
08/04/2005WO2005045001A3 Insulin-producing cells derived from stem cells
08/04/2005WO2005042715A3 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005035715A8 Flanking dna sequences that control expression in the human genome
08/04/2005WO2005033283A3 Methods for enhancing the analysis of particle detection
08/04/2005WO2005026328A3 Cpt resistant cell line
08/04/2005WO2005023994A3 Modified oligonucleotides for telomerase inhibition
08/04/2005WO2005003323A3 Use of calcium binding proteins to improve cardiac contractile function
08/04/2005WO2005001059A3 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
08/04/2005WO2005001045A3 Materials and methods for production of fruit-free, pollen-free plants with large showy flowers
08/04/2005WO2005001027A2 Compositions for down-regulation of ccr5 expression and methods of use therefor
08/04/2005WO2004104168A3 Mrbs as modifiers of the rb pathway and methods of use
08/04/2005WO2004081193A3 Method for producing ethanol using raw starch
08/04/2005US20050172359 Using expression vector comprising phaseolin promoter to transfer and express plasma lipoprotein in seeds
08/04/2005US20050171041 Identifying drug targets; assaying for expression of candidate ribonucleic acid in RNAi pathway molecule and svRNA
08/04/2005US20050170502 Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170443 Methods and use of binding components for improving assay specificity
08/04/2005US20050170440 Treatment and diagnosis of insulin-resistant states
08/04/2005US20050170431 PYK2 crystal structure and uses
08/04/2005US20050170330 Using transgenic angiogenic progenitor cells to diagnosis neovascularization and tumor development
08/04/2005US20050169942 Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeutics
08/04/2005US20050169934 Computer assisted modeling of tumor antigen bound in major histocompatibility complex I groove; substituting at least first amino acid located in cytotoxic T lymphocyte epitope; reducing interference with T cell receptor binding; HER-2 related cancer
08/04/2005US20050169894 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of Type III and/or Type IV phosphodiesterases
08/04/2005US20050169848 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
08/03/2005EP1558763A2 Identification of diet-regulated disease-associated genes
08/03/2005EP1558748A2 Cell lysis compositions, methods of use, apparatus, and kit
08/03/2005EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby
08/03/2005CN1650020A Means and methods for the production of adenovirus vectors
08/02/2005US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara
08/02/2005US6924118 Recombinant intracellular pathogen immunogenic compositions and methods for use
08/02/2005US6924109 High-throughput transcriptome and functional validation analysis
08/02/2005US6923993 Process of isolating extract from the Euphorbia obesa plant and methods for using the same
08/02/2005US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation
08/02/2005CA2341081C Cloning and expression of microbial phytase
07/2005
07/28/2005WO2005067629A2 Cancer-linked genes as targets for chemotherapy
07/28/2005WO2005054438A3 Nucleic acid molecules containing recombination sites and methods of using the same
07/28/2005WO2005042694A3 Multi-stage microbial system for continuous hydrogen production
07/28/2005WO2005035727A3 Polymer derivatives
07/28/2005WO2005030935A3 Adjuvant activities of mutants of lt-iia and lt-iib enterotoxin lacking binding to ganglioside
07/28/2005WO2005030931A3 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
07/28/2005WO2005021730A3 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
07/28/2005WO2005017102A3 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
07/28/2005WO2005003300A3 Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same
07/28/2005WO2005003289A3 Ap1 amine oxidase variants
07/28/2005WO2004096991A3 Bcl2l12 polypeptide activators and inhibitors
07/28/2005WO2004092392A3 A method for producing para-hydroxystyrene and other multifunctional aromatic compounds using two-phase extractive fermentation
07/28/2005WO2004083377A3 Microorganism-templated nanoparticle assembly
07/28/2005WO2004053093A3 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating
07/28/2005WO2004015076A3 Novel proteins and nucleic acids encoding same
07/28/2005WO2003099196A3 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
07/28/2005US20050166289 Small interfering RNA (siRNA)-mediated heritable gene manipulation in plants
07/28/2005US20050165089 Compounds, compositions and methods
07/28/2005US20050164300 Molecular scaffolds for kinase ligand development
07/28/2005US20050164235 Modified iRNA agents
07/28/2005US20050163772 B7S1: an immune modulator
07/28/2005US20050163759 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of type I and/or type II phosphodiesterases
07/28/2005DE10359594A1 PEF-TU-Expressionseinheiten PEF-TU-expression units
07/27/2005EP1556511A2 Reverse transcription on microarrays
07/27/2005EP1556491A2 Herbicide-resistant plants, and polynucleotides and methods for providing same
07/27/2005EP1556081A2 Recombinant intracellular pathogen immunogenic compositions and methods for use
07/27/2005EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods
07/27/2005CN1646160A Anti-alpha V beta 6 antibodies
07/27/2005CN1644693A Protein having tpo activity
07/26/2005US6921849 Dwarfism genes and dwarf plants
07/26/2005US6921643 Using template directed dye termination and fluorescence polarization detection to identify pine species containing restriction fragment length polymorphism associated with altered lignin composition
07/21/2005WO2005047473A3 Single vector dual gene therapy for pulmonary hypertension
07/21/2005WO2005047470A3 Intercalator fret donors or acceptors
07/21/2005WO2005047455A3 Methods for the production of apolipoproteins in transgenic plants
07/21/2005WO2005040399A3 Methods for quantitative determination of methylation density in a dna locus
07/21/2005WO2005040337A3 METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
07/21/2005WO2005037991A3 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis
07/21/2005WO2005026316A8 Alphavirus vaccines
07/21/2005WO2005007819A3 Charge-dynamic polymers and delivery of anionic compounds
07/21/2005WO2005003313A3 Methods and compositions for enhanced protein expression and purification
07/21/2005WO2004096988A8 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance
07/21/2005WO2004090109A3 Ccn3 compositions and methods
07/21/2005WO2004018648A3 Methods for treating patients and identifying therapeutics
07/21/2005US20050159606 Fluorescent dye-fused lactone derivative covalently attaches to biological agent; xanthene or phenoxazine derivatives; chroman-2-one dyes; phosphoramidite linkages
07/21/2005US20050158739 Using methylation status/profile of gene sequences as diagnostic tool in detection of cell proliferative disorders
07/21/2005US20050158373 Method and carrier complexes for delivering molecules to cells
07/21/2005US20050158311 Via contacting cell with agent that binds Ryk polypeptides, inhibiting signal transduction; for amelioration of cancer
07/21/2005US20050158288 Methods of organ regeneration
07/21/2005US20050158278 Means and methods for the production of adenovirus vectors
07/20/2005EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
07/20/2005CN1643142A Method of identifying genes controlling diferentiation
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 100